Iceland· IS-EU/1/15/1059/001

Orkambi

A ivacaftor and lumacaftor product containing lumacaftorum inn,ivacaftorum inn, registered in Iceland by Vertex Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 16 of our 19 countries.

ATC R07AX30

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedOrkambiATCR07AX30REGISTER NO.IS-EU/1/15/1059/001PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Ivacaftor and lumacaftor is registered in 16 of 19 countries.

Countries holding a registration under ATC R07AX30 (ivacaftor and lumacaftor), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 11 of them publish a price we can compare per daily dose

Ivacaftor and lumacaftor · ATC R07AX30

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Lumacaftorum INN,Ivacaftorum INN
Manufacturer
Vertex Pharmaceuticals (Ireland) Limited
Country
Iceland (IS)
ATC code
R07AX30
ATC class
Ivacaftor and lumacaftor
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7aa9481-18ca-4a72-b856-9a509990157d
GET /v1/drugs/c7aa9481-18ca-4a72-b856-9a509990157d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "R07AX30",
  "marketed": false,
  "strength": "200 mg/125 mg",
  "ma_number": "EU/1/15/1059/001",
  "substance": "Lumacaftorum INN,Ivacaftorum INN",
  "other_info": "Ávísun lyfsins er bundin við barnalækna með sérþekkingu á slímseigjusjúkdómi og sérfræðinga í lungnalækningum.",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "42327"
}

See everything about ivacaftor and lumacaftor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.